Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein ZIC2 (ZIC2) is a transcription factor of the ZIC family characterized by five C2H2-type zinc finger domains that enable binding to DNA and regulatory proteins[1][6][7]. It is critically involved in embryonic brain development, including patterning of the forebrain, neural tube closure, formation of the left-right body axis, and retinal axon guidance[1][4][5]. ZIC2 modulates gene expression primarily through transcriptional repression, acting at enhancer regions, and functions in chromatin remodeling and regulation of embryonic stem cell fate by interacting with the NuRD complex[2][3]. Mutations in ZIC2 cause holoprosencephaly type 5 and are associated with neural tube defects and various midline developmental anomalies[1][4][7]. Overexpression of ZIC2 has been linked with tumorigenesis, cancer progression, and poor prognosis in several malignancies, and abnormal ZIC2 activity impacts immune regulation and genomic stability[6]. No drugs are currently known to directly target ZIC2.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein ZIC2 (ZIC2).